CD44 and ovarian cancer: In addition, the histopathological examination showed that after the combinatorial therapy, magnetic-induced heating of the CD44-shRNA/DDP nanoliposomes in this study selectively targeted ovarian cancer tissues and caused no damage to the visceras including the heart, liver, spleen, lung, kidney, brain, and pancreas (Figure 8).